No Detail Found!

Clinical Efficacy of LivPro ® Herbal Medicine among Hepatitis C Patients Pakistan: Longitudinal Interventional Study

Author(s)
Irfan Shahid Block B Gulshan-e-Ravi, Lahore, Punjab ,Pakistan
Kashif Maqbool Khan Institute of Pharmaceutical Science, University of Veterinary and Animal Sciences, City Campus,,Pakistan
Tahir Mehmood Khan Institute of Pharmaceutical Science, University of Veterinary and Animal Sciences, City Campus, Pakistan. School of Pharmacy, Monash University, Bandar Sunway, Selangor Malaysia.
Muhammad Saeed Imran Department of Pathology, University of Veterinary and Animal Sciences, City Campus,,Pakistan
Nabeel Shahid Institute of Pharmaceutical Science, University of Veterinary and Animal Sciences, City Campus,,Pakistan
Farah Nofal Alnafoosi Department of Emergency Medicine, Clemenceau Medical Center, Al Jaddaf - Dubai - United Arab Emirates.
Mirza Rafi Baig Department of Clinical Pharmacy & Pharmacotherapeutics, Dubai Pharmacy College for Girls, United Arab Emirates.
Yaser Mohammed Al-Worafi College of Pharmacy, University of Science and Technology of Fujairah,Fujairah,United Arab Emirates
Abstract
The current study aims to investigate the hepatoprotective effects of LivPro® among hepatitis C patients. An interventional study was performed among n=89 hepatitis C patients. The duration of the study was 3 months and the assessment for liver function, ELISA, and Viral load was performed monthly for the patients recruited in this study. Mean difference was measured and at a Confidence Interval (CI 95%) pvalue less than 0.05 was considered statistically significant. This interventional study was comprised of 89 patients who directly participated in this study. Of whom 52 (58.0%) were men and the remaining 42% were women. All the patients were hepatitis C positive at the time of recruitment of study. Overall, it is observed that improvement in ALT at the endpoint assessment was -23.13 [ -31.96 - -14.30] in comparison to the baseline (p=<0.0001). Similarly, the improvement in AST and ALP was also significant (p=<0.0006; p=<0.0001). There was a significant decline in the Anti-HCV ELISA however, regardless of the decline the viral load was not found statistically significant at the end of the study. LivPro® is beneficial in improving the hepatic biomarkers of the patients suffering from Hepatitis C.
Publication Details
Page(s) 54-57
Published Journal: Archives of Pharmacy Practice, Volume: 12, Issue: 4, Year: 2021

Request the full text from PASTIC

Keywords
Liver, hepatitis C, Anti-HCV ELISA, LivPro®
References
.2019 .diseases in the world. J Hepatol, 70(1) : 151-71.
.2018 .. doi:10, 09 : .
Int J Pharm Res Allied Sci .2020 .. , 9(1) : 70-4.
Des .2010 .. , 10(6) : 741-52.
Open India. Pharmacoecon .2018 .. , 10(2) : 179-90.
.2012 .HIV/HCV. , 10(4) : 370-8.
. .infection in 2015: a modelling study. Lancet Gastroenterol Hepatol., : .
.2017 .. , 1253(16) : 30181-9.
Lancet success. .2018 .. , 10(10123) : 834-5.
.2016 .challenges and progress. World J Gastroenterol, 22(25) : 5837.
. .. doi:10.3748/wjg.v22.i25.5837, : .
Awamilab. LivePro .2021 .. , : .
. .. , : .
.2014 .. World J Gastroenterol, 20(25) : 8082.
. .. doi:10.3748/wjg.v20.i25.8082, : .
Res Jian). Aquac .2016 .. , 10(6) : 1852-63.
Wu JG,Kan YJ,Wu YB,Yi J,Chen TQ,Wu JZ .2015 .Hepatoprotective effect of ganoderma triterpenoids against oxidative damage induced by tert-butyl hydroperoxide in human hepatic HepG2 cells. Pharm Biol, 10(5) : 919-29.
Kalantari H,Foruozandeh H,Khodayar MJ,Siahpoosh A,Saki N,Kheradmand P .2017 .Antioxidant and hepatoprotective effects of Capparis spinosa L. fractions and Quercetin on tert-butyl hydroperoxide-induced acute liver damage in mice. J Tradit Complement Med, 04(1) : 120-7.
Faraji S,Daneghian S,Alizadeh M. .2020 .Effects of chicory (Cichorium intybus L.) on nonalcoholic fatty liver disease. Tradit Med Res, 10(6) : 476-86.
Arena A,Bisignano G,Pavone B,Tomaino A,Bonina F,Saija A .2008 .Antiviral and immunomodulatory effect of a lyophilized extract of Capparis spinosa L. buds. Phytother Res, 10(3) : 313-7.
Reinke RA,Lee DJ,McDougall BR,King PJ,Victoria J,Mao Y .2004 .L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro. Virology, 06(2) : 203-19.
Javed T,Ashfaq UA,Riaz S,Rehman S,Riazuddin S. .2011 .In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus. , 10(1) : 8-7.
Pause A,Kukolj G,Bailey M,Brault M,Dô F,Halmos T .2003 .An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA. J Biol Chem, 10(22) : 20374-80.
Borowski P,Heiland M,Oehlmann K,Becker B,Kornetzky L,Feucht H .1996 .Non‐Structural Protein 3 of Hepatitis C Virus Inhibits Phosphorylation Mediated by cAMP‐Dependent Protein Kinase. Eur J Biochem, 10(3) : 1033-8.
Sakamuro D,Furukawa T,Takegami T .1995 .Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol, 10(6) : 3893-3896.
Subash K,Ramesh K,Charian BV,Britto F,Rao NJ,Vijaykumar S. .2011 .Study of hepatoprotective activity of Solanum nigrum and Cichorium intybus. Int J Pharmacol, 504(4) : 504-9.
Duke JA .2016 .Promising herbs and phytochemicals for chronic hepatitis C virus infection. J Am Herbal Guild, 14(1) : 60-74.
Sajitha Lulu S,Thabitha A,Vino S,Mohana Priya A,Rout M. Naringenin .2015 .and quercetin-potential anti-HCV agents for NS2 protease targets. Nat Prod Res, 10(4) : 464-8.
Jafri M,Subhani MJ,Javed K,Singh S K .1999 .Hepatoprotective activity of leaves of Cassia occidentalis against paracetamol and ethyl alcohol intoxication in rats. J Ethnopharmacol, 8741(99) : 00037-9.
Usha K,Kasturi GM,Hemalatha P .2007 .Hepatoprotective effect ofHygrophila spinosa andCassia occidentalis on carbon tetrachloride induced liver damage in experimental rats. Indian J Clin Biochem, 10(2) : 132-5.
Gbadegesin MA,Odunola OA .2013 .In vitro antioxidant/radical scavenging activities and hepatoprotective roles of ethanolic extract of Cassia occidentalis leaves in sodium arsenite-treated male Wistar rats. J Adv Med Med Res, 10 : 2141-56.
Savita S,Srivastava AK,Sudhir S,Patnaik G,Dhawan B .1994 .Effect of picroliv and silymarin on liver regeneration in rats. Indian J Pharmacol, 26(1) : 19.
0

Citations

0

Downloads

8

Views